99% Savings - Buy Just @1 Rs X
Pramitrem 0.52 Tablet XR is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of Parkinson's Disease. Secondary and off-label uses of Pramitrem 0.52 Tablet XR have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Pramitrem 0.52 Tablet XR. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Pramitrem 0.52 Tablet XR as well, which are listed below. Normally, these side effects of Pramitrem 0.52 Tablet XR are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
In addition, Pramitrem 0.52 Tablet XR's effect is Moderate during pregnancy and Severe for lactating mothers. Further, the section on Pramitrem 0.52 Tablet XR related warnings talks about Pramitrem 0.52 Tablet XR's effects on the liver, heart and kidney.
Pramitrem 0.52 Tablet XR is contraindicated in people with pre-existing medical conditions like Schizophrenia, Heart Disease, Kidney Disease as it can result in adverse effects.
Drug reaction of Pramitrem 0.52 Tablet XR with other medicines has been reported. Refer to the list below for further details.
In addition to these precautions, you may also note that Pramitrem 0.52 Tablet XR is not safe while driving, and is is not addictive in nature.
Pramitrem 0.52 Tablet XR is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Pramitrem 0.52 Tablet XR safe for pregnant women?
Pramitrem may have some side effects during pregnancy. Pregnant women should discontinue the use of Pramitrem, and talk to their doctor, if they notice any discomfort.
Is the use of Pramitrem 0.52 Tablet XR safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Pramitrem. It should only be taken after medical advice.
What is the effect of Pramitrem 0.52 Tablet XR on the Kidneys?
Pramitrem has very mild side effects on the kidneys.
What is the effect of Pramitrem 0.52 Tablet XR on the Liver?
Pramitrem does not damage the liver.
What is the effect of Pramitrem 0.52 Tablet XR on the Heart?
Pramitrem has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Pramitrem 0.52 Tablet XR unless your doctor advises you to do so -
Is this Pramitrem 0.52 Tablet XR habit forming or addictive?
Forming a habit of Pramitrem 0.52 Tablet XR has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Pramitrem 0.52 Tablet XR can make you feel drowsy.
Is it safe?
Pramitrem 0.52 Tablet XR should be used only after doctor's advice.
Is it able to treat mental disorders?
Yes, in many cases, taking Pramitrem 0.52 Tablet XR can help with mental disorders.
Interaction between Food and Pramitrem 0.52 Tablet XR
Some foods when eaten with Pramitrem 0.52 Tablet XR can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Pramitrem 0.52 Tablet XR
Taking alcohol with Pramitrem 0.52 Tablet XR can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Mirapex® (pramipexole dihydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1043-1044
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 430-431